nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—HSPA5—hematologic cancer	0.14	0.403	CbGaD
Acetylsalicylic acid—NFKBIA—hematologic cancer	0.13	0.375	CbGaD
Acetylsalicylic acid—migraine—Prednisone—hematologic cancer	0.103	0.508	CpDpCtD
Acetylsalicylic acid—osteoarthritis—Prednisone—hematologic cancer	0.1	0.492	CpDpCtD
Acetylsalicylic acid—TP53—hematologic cancer	0.0578	0.166	CbGaD
Acetylsalicylic acid—PTGS2—Lenalidomide—hematologic cancer	0.0186	0.082	CbGbCtD
Acetylsalicylic acid—ALB—hematologic cancer	0.0101	0.0289	CbGaD
Acetylsalicylic acid—PTGS2—Thalidomide—hematologic cancer	0.00994	0.0438	CbGbCtD
Acetylsalicylic acid—PTGS1—Bortezomib—hematologic cancer	0.00964	0.0425	CbGbCtD
Acetylsalicylic acid—ABCB1—hematologic cancer	0.00961	0.0276	CbGaD
Acetylsalicylic acid—PTGS1—Thalidomide—hematologic cancer	0.00839	0.037	CbGbCtD
Acetylsalicylic acid—PTGS1—Ifosfamide—hematologic cancer	0.00739	0.0326	CbGbCtD
Acetylsalicylic acid—PTGS1—Imatinib—hematologic cancer	0.00706	0.0311	CbGbCtD
Acetylsalicylic acid—PTGS2—Triamcinolone—hematologic cancer	0.00689	0.0304	CbGbCtD
Acetylsalicylic acid—CYP2C9—Bexarotene—hematologic cancer	0.00633	0.0279	CbGbCtD
Acetylsalicylic acid—ABCB1—Lenalidomide—hematologic cancer	0.00614	0.0271	CbGbCtD
Acetylsalicylic acid—PTGS2—Betamethasone—hematologic cancer	0.00591	0.026	CbGbCtD
Acetylsalicylic acid—CYP2C8—Bortezomib—hematologic cancer	0.00556	0.0245	CbGbCtD
Acetylsalicylic acid—ALB—Imatinib—hematologic cancer	0.00527	0.0232	CbGbCtD
Acetylsalicylic acid—CYP2C9—Idarubicin—hematologic cancer	0.00524	0.0231	CbGbCtD
Acetylsalicylic acid—SLC22A7—Methotrexate—hematologic cancer	0.00481	0.0212	CbGbCtD
Acetylsalicylic acid—CYP2C19—Bortezomib—hematologic cancer	0.00467	0.0206	CbGbCtD
Acetylsalicylic acid—CYP2C8—Ifosfamide—hematologic cancer	0.00426	0.0188	CbGbCtD
Acetylsalicylic acid—PTGS2—Cisplatin—hematologic cancer	0.00426	0.0188	CbGbCtD
Acetylsalicylic acid—PTGS2—Etoposide—hematologic cancer	0.00418	0.0184	CbGbCtD
Acetylsalicylic acid—CYP2C19—Thalidomide—hematologic cancer	0.00406	0.0179	CbGbCtD
Acetylsalicylic acid—CYP2C9—Bortezomib—hematologic cancer	0.00388	0.0171	CbGbCtD
Acetylsalicylic acid—CYP2C19—Teniposide—hematologic cancer	0.00388	0.0171	CbGbCtD
Acetylsalicylic acid—CYP2C8—Nilotinib—hematologic cancer	0.0037	0.0163	CbGbCtD
Acetylsalicylic acid—ABCB1—Daunorubicin—hematologic cancer	0.0036	0.0159	CbGbCtD
Acetylsalicylic acid—CYP2C19—Ifosfamide—hematologic cancer	0.00358	0.0158	CbGbCtD
Acetylsalicylic acid—PTGS1—Etoposide—hematologic cancer	0.00353	0.0156	CbGbCtD
Acetylsalicylic acid—ABCB1—Alitretinoin—hematologic cancer	0.00353	0.0155	CbGbCtD
Acetylsalicylic acid—ALB—Prednisone—hematologic cancer	0.00347	0.0153	CbGbCtD
Acetylsalicylic acid—PTGS2—Dexamethasone—hematologic cancer	0.00344	0.0152	CbGbCtD
Acetylsalicylic acid—CYP2C19—Imatinib—hematologic cancer	0.00342	0.0151	CbGbCtD
Acetylsalicylic acid—CYP2C9—Thalidomide—hematologic cancer	0.00338	0.0149	CbGbCtD
Acetylsalicylic acid—ALB—Irinotecan—hematologic cancer	0.00329	0.0145	CbGbCtD
Acetylsalicylic acid—CYP2C9—Teniposide—hematologic cancer	0.00322	0.0142	CbGbCtD
Acetylsalicylic acid—CYP2C9—Ifosfamide—hematologic cancer	0.00297	0.0131	CbGbCtD
Acetylsalicylic acid—CYP2C9—Imatinib—hematologic cancer	0.00284	0.0125	CbGbCtD
Acetylsalicylic acid—ABCB1—Imatinib—hematologic cancer	0.00276	0.0122	CbGbCtD
Acetylsalicylic acid—CYP2C9—Nilotinib—hematologic cancer	0.00258	0.0114	CbGbCtD
Acetylsalicylic acid—ABCB1—Nilotinib—hematologic cancer	0.00251	0.011	CbGbCtD
Acetylsalicylic acid—ABCB1—Vinorelbine—hematologic cancer	0.00249	0.0109	CbGbCtD
Acetylsalicylic acid—CYP2C19—Prednisone—hematologic cancer	0.00225	0.00992	CbGbCtD
Acetylsalicylic acid—ABCB1—Dasatinib—hematologic cancer	0.00221	0.00976	CbGbCtD
Acetylsalicylic acid—ABCB1—Mitoxantrone—hematologic cancer	0.00219	0.00964	CbGbCtD
Acetylsalicylic acid—SLC22A6—Methotrexate—hematologic cancer	0.00205	0.00902	CbGbCtD
Acetylsalicylic acid—CYP2C8—Etoposide—hematologic cancer	0.00204	0.00898	CbGbCtD
Acetylsalicylic acid—PTGS2—ovarian follicle—hematologic cancer	0.00196	0.0625	CbGeAlD
Acetylsalicylic acid—ABCB1—Betamethasone—hematologic cancer	0.00195	0.00859	CbGbCtD
Acetylsalicylic acid—ABCB1—Gemcitabine—hematologic cancer	0.00193	0.00851	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisolone—hematologic cancer	0.00192	0.00848	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisone—hematologic cancer	0.00182	0.00801	CbGbCtD
Acetylsalicylic acid—ALB—Methotrexate—hematologic cancer	0.00174	0.00768	CbGbCtD
Acetylsalicylic acid—ABCB1—Irinotecan—hematologic cancer	0.00172	0.00759	CbGbCtD
Acetylsalicylic acid—CYP2C8—Dexamethasone—hematologic cancer	0.00168	0.00738	CbGbCtD
Acetylsalicylic acid—ABCB1—Vinblastine—hematologic cancer	0.00153	0.00675	CbGbCtD
Acetylsalicylic acid—ABCB1—Vincristine—hematologic cancer	0.00151	0.00663	CbGbCtD
Acetylsalicylic acid—CYP2C9—Cisplatin—hematologic cancer	0.00145	0.00637	CbGbCtD
Acetylsalicylic acid—CYP2C19—Dexamethasone—hematologic cancer	0.00141	0.00619	CbGbCtD
Acetylsalicylic acid—ABCB1—Cisplatin—hematologic cancer	0.0014	0.00619	CbGbCtD
Acetylsalicylic acid—ABCB1—Etoposide—hematologic cancer	0.00138	0.00608	CbGbCtD
Acetylsalicylic acid—TP53—hematopoietic system—hematologic cancer	0.00123	0.0391	CbGeAlD
Acetylsalicylic acid—NFKBIA—hematopoietic system—hematologic cancer	0.00121	0.0385	CbGeAlD
Acetylsalicylic acid—HSPA5—hematopoietic system—hematologic cancer	0.00119	0.0377	CbGeAlD
Acetylsalicylic acid—CYP2C9—Dexamethasone—hematologic cancer	0.00117	0.00515	CbGbCtD
Acetylsalicylic acid—ABCB1—Dexamethasone—hematologic cancer	0.00113	0.005	CbGbCtD
Acetylsalicylic acid—RPS6KA3—hematopoietic system—hematologic cancer	0.00101	0.0321	CbGeAlD
Acetylsalicylic acid—ABCB1—Doxorubicin—hematologic cancer	0.000941	0.00415	CbGbCtD
Acetylsalicylic acid—TP53—gonad—hematologic cancer	0.000935	0.0298	CbGeAlD
Acetylsalicylic acid—NFKBIA—gonad—hematologic cancer	0.00092	0.0293	CbGeAlD
Acetylsalicylic acid—ABCB1—Methotrexate—hematologic cancer	0.000912	0.00402	CbGbCtD
Acetylsalicylic acid—HSPA5—gonad—hematologic cancer	0.000901	0.0287	CbGeAlD
Acetylsalicylic acid—TP53—blood—hematologic cancer	0.000815	0.0259	CbGeAlD
Acetylsalicylic acid—NFKBIA—blood—hematologic cancer	0.000802	0.0255	CbGeAlD
Acetylsalicylic acid—TP53—bone marrow—hematologic cancer	0.000788	0.0251	CbGeAlD
Acetylsalicylic acid—HSPA5—blood—hematologic cancer	0.000785	0.025	CbGeAlD
Acetylsalicylic acid—NFKBIA—bone marrow—hematologic cancer	0.000776	0.0247	CbGeAlD
Acetylsalicylic acid—HSPA5—bone marrow—hematologic cancer	0.00076	0.0242	CbGeAlD
Acetylsalicylic acid—IKBKB—hematopoietic system—hematologic cancer	0.000745	0.0237	CbGeAlD
Acetylsalicylic acid—TP53—lung—hematologic cancer	0.000714	0.0227	CbGeAlD
Acetylsalicylic acid—NFKBIA—lung—hematologic cancer	0.000703	0.0224	CbGeAlD
Acetylsalicylic acid—HSPA5—lung—hematologic cancer	0.000688	0.0219	CbGeAlD
Acetylsalicylic acid—TP53—testis—hematologic cancer	0.000674	0.0215	CbGeAlD
Acetylsalicylic acid—RPS6KA3—blood—hematologic cancer	0.000669	0.0213	CbGeAlD
Acetylsalicylic acid—NFKBIA—testis—hematologic cancer	0.000663	0.0211	CbGeAlD
Acetylsalicylic acid—HSPA5—testis—hematologic cancer	0.000649	0.0207	CbGeAlD
Acetylsalicylic acid—RPS6KA3—bone marrow—hematologic cancer	0.000647	0.0206	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lung—hematologic cancer	0.000586	0.0187	CbGeAlD
Acetylsalicylic acid—IKBKB—gonad—hematologic cancer	0.000567	0.018	CbGeAlD
Acetylsalicylic acid—RPS6KA3—testis—hematologic cancer	0.000553	0.0176	CbGeAlD
Acetylsalicylic acid—IKBKB—blood—hematologic cancer	0.000494	0.0157	CbGeAlD
Acetylsalicylic acid—TP53—lymph node—hematologic cancer	0.000489	0.0155	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—hematologic cancer	0.000481	0.0153	CbGeAlD
Acetylsalicylic acid—EDNRA—lung—hematologic cancer	0.000477	0.0152	CbGeAlD
Acetylsalicylic acid—HSPA5—lymph node—hematologic cancer	0.000471	0.015	CbGeAlD
Acetylsalicylic acid—EDNRA—testis—hematologic cancer	0.00045	0.0143	CbGeAlD
Acetylsalicylic acid—IKBKB—lung—hematologic cancer	0.000433	0.0138	CbGeAlD
Acetylsalicylic acid—IKBKB—testis—hematologic cancer	0.000408	0.013	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymph node—hematologic cancer	0.000401	0.0128	CbGeAlD
Acetylsalicylic acid—SLC22A7—testis—hematologic cancer	0.000396	0.0126	CbGeAlD
Acetylsalicylic acid—CYP2C19—hematopoietic system—hematologic cancer	0.00035	0.0111	CbGeAlD
Acetylsalicylic acid—EDNRA—lymph node—hematologic cancer	0.000326	0.0104	CbGeAlD
Acetylsalicylic acid—Meclofenamic acid—ALOX5—hematologic cancer	0.000314	0.792	CrCbGaD
Acetylsalicylic acid—CYP2C8—hematopoietic system—hematologic cancer	0.000306	0.00973	CbGeAlD
Acetylsalicylic acid—IKBKB—lymph node—hematologic cancer	0.000296	0.00942	CbGeAlD
Acetylsalicylic acid—CYP2C9—hematopoietic system—hematologic cancer	0.000272	0.00864	CbGeAlD
Acetylsalicylic acid—PTGS1—hematopoietic system—hematologic cancer	0.000248	0.00789	CbGeAlD
Acetylsalicylic acid—ALB—testis—hematologic cancer	0.000238	0.00759	CbGeAlD
Acetylsalicylic acid—PTGS2—hematopoietic system—hematologic cancer	0.000237	0.00754	CbGeAlD
Acetylsalicylic acid—CYP2C19—blood—hematologic cancer	0.000232	0.00738	CbGeAlD
Acetylsalicylic acid—CYP2C8—blood—hematologic cancer	0.000203	0.00645	CbGeAlD
Acetylsalicylic acid—TP53—Podofilox—Teniposide—hematologic cancer	0.000201	0.0963	CbGdCrCtD
Acetylsalicylic acid—CYP2C9—blood—hematologic cancer	0.00018	0.00573	CbGeAlD
Acetylsalicylic acid—ALB—lymph node—hematologic cancer	0.000173	0.0055	CbGeAlD
Acetylsalicylic acid—CYP2C8—testis—hematologic cancer	0.000168	0.00533	CbGeAlD
Acetylsalicylic acid—PTGS1—blood—hematologic cancer	0.000164	0.00523	CbGeAlD
Acetylsalicylic acid—PTGS2—blood—hematologic cancer	0.000157	0.005	CbGeAlD
Acetylsalicylic acid—NFKBIA—Podofilox—Teniposide—hematologic cancer	0.000152	0.0729	CbGdCrCtD
Acetylsalicylic acid—PTGS2—bone marrow—hematologic cancer	0.000152	0.00483	CbGeAlD
Acetylsalicylic acid—ABCB1—hematopoietic system—hematologic cancer	0.000147	0.00466	CbGeAlD
Acetylsalicylic acid—PTGS1—lung—hematologic cancer	0.000144	0.00458	CbGeAlD
Acetylsalicylic acid—PTGS2—lung—hematologic cancer	0.000138	0.00438	CbGeAlD
Acetylsalicylic acid—PTGS1—testis—hematologic cancer	0.000136	0.00432	CbGeAlD
Acetylsalicylic acid—NFKBIA—Doxorubicin—Daunorubicin—hematologic cancer	0.000136	0.065	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Epirubicin—Daunorubicin—hematologic cancer	0.000136	0.065	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Daunorubicin—hematologic cancer	0.000136	0.065	CbGdCrCtD
Acetylsalicylic acid—TP53—Vincristine—Vinorelbine—hematologic cancer	0.000128	0.0613	CbGdCrCtD
Acetylsalicylic acid—TP53—Podofilox—Etoposide—hematologic cancer	0.000119	0.0572	CbGdCrCtD
Acetylsalicylic acid—ABCB1—gonad—hematologic cancer	0.000111	0.00355	CbGeAlD
Acetylsalicylic acid—NFKBIA—Epirubicin—Idarubicin—hematologic cancer	0.000103	0.0493	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Doxorubicin—Idarubicin—hematologic cancer	0.000103	0.0493	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Idarubicin—hematologic cancer	0.000103	0.0493	CbGdCrCtD
Acetylsalicylic acid—TP53—Vincristine—Vinblastine—hematologic cancer	0.000102	0.049	CbGdCrCtD
Acetylsalicylic acid—PTGS1—lymph node—hematologic cancer	9.85e-05	0.00313	CbGeAlD
Acetylsalicylic acid—ABCB1—blood—hematologic cancer	9.71e-05	0.00309	CbGeAlD
Acetylsalicylic acid—NFKBIA—Vincristine—Vinorelbine—hematologic cancer	9.68e-05	0.0464	CbGdCrCtD
Acetylsalicylic acid—PTGS2—lymph node—hematologic cancer	9.41e-05	0.003	CbGeAlD
Acetylsalicylic acid—ABCB1—bone marrow—hematologic cancer	9.4e-05	0.00299	CbGeAlD
Acetylsalicylic acid—NFKBIA—Podofilox—Etoposide—hematologic cancer	9.04e-05	0.0434	CbGdCrCtD
Acetylsalicylic acid—ABCB1—lung—hematologic cancer	8.51e-05	0.00271	CbGeAlD
Acetylsalicylic acid—ABCB1—testis—hematologic cancer	8.03e-05	0.00256	CbGeAlD
Acetylsalicylic acid—NFKBIA—Vincristine—Vinblastine—hematologic cancer	7.74e-05	0.0371	CbGdCrCtD
Acetylsalicylic acid—ABCB1—lymph node—hematologic cancer	5.82e-05	0.00185	CbGeAlD
Acetylsalicylic acid—NFKBIA—Doxorubicin—Epirubicin—hematologic cancer	4.72e-05	0.0226	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Epirubicin—hematologic cancer	4.72e-05	0.0226	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Epirubicin—hematologic cancer	4.72e-05	0.0226	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Epirubicin—Doxorubicin—hematologic cancer	4.36e-05	0.0209	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Daunorubicin—Doxorubicin—hematologic cancer	4.36e-05	0.0209	CbGdCrCtD
Acetylsalicylic acid—NFKBIA—Idarubicin—Doxorubicin—hematologic cancer	4.36e-05	0.0209	CbGdCrCtD
Acetylsalicylic acid—Salicylic acid—ALB—hematologic cancer	4.22e-05	0.106	CrCbGaD
Acetylsalicylic acid—Salicylic acid—ABCB1—hematologic cancer	4.03e-05	0.102	CrCbGaD
Acetylsalicylic acid—TP53—Testosterone—Prednisolone—hematologic cancer	2.5e-05	0.012	CbGdCrCtD
Acetylsalicylic acid—Shock—Triamcinolone—hematologic cancer	2.27e-05	0.000261	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Etoposide—hematologic cancer	2.27e-05	0.000261	CcSEcCtD
Acetylsalicylic acid—Dizziness—Thalidomide—hematologic cancer	2.27e-05	0.000261	CcSEcCtD
Acetylsalicylic acid—Somnolence—Etoposide—hematologic cancer	2.26e-05	0.00026	CcSEcCtD
Acetylsalicylic acid—Nausea—Bortezomib—hematologic cancer	2.26e-05	0.00026	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Dexamethasone—hematologic cancer	2.26e-05	0.00026	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Betamethasone—hematologic cancer	2.26e-05	0.00026	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Mitoxantrone—hematologic cancer	2.26e-05	0.00026	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Irinotecan—hematologic cancer	2.26e-05	0.00026	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Triamcinolone—hematologic cancer	2.25e-05	0.000259	CcSEcCtD
Acetylsalicylic acid—Vomiting—Thiotepa—hematologic cancer	2.25e-05	0.000259	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Carmustine—hematologic cancer	2.25e-05	0.000259	CcSEcCtD
Acetylsalicylic acid—Nausea—Bleomycin—hematologic cancer	2.24e-05	0.000258	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Epirubicin—hematologic cancer	2.24e-05	0.000258	CcSEcCtD
Acetylsalicylic acid—Rash—Thiotepa—hematologic cancer	2.24e-05	0.000257	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Thiotepa—hematologic cancer	2.23e-05	0.000257	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Triamcinolone—hematologic cancer	2.23e-05	0.000257	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Alitretinoin—hematologic cancer	2.23e-05	0.000257	CcSEcCtD
Acetylsalicylic acid—Convulsion—Dexamethasone—hematologic cancer	2.23e-05	0.000256	CcSEcCtD
Acetylsalicylic acid—Convulsion—Betamethasone—hematologic cancer	2.23e-05	0.000256	CcSEcCtD
Acetylsalicylic acid—Hypertension—Betamethasone—hematologic cancer	2.22e-05	0.000255	CcSEcCtD
Acetylsalicylic acid—Hypertension—Dexamethasone—hematologic cancer	2.22e-05	0.000255	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Ifosfamide—hematologic cancer	2.21e-05	0.000254	CcSEcCtD
Acetylsalicylic acid—Nausea—Vinorelbine—hematologic cancer	2.21e-05	0.000254	CcSEcCtD
Acetylsalicylic acid—Vomiting—Thalidomide—hematologic cancer	2.18e-05	0.000251	CcSEcCtD
Acetylsalicylic acid—Dizziness—Carmustine—hematologic cancer	2.18e-05	0.000251	CcSEcCtD
Acetylsalicylic acid—Rash—Thalidomide—hematologic cancer	2.16e-05	0.000249	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Thalidomide—hematologic cancer	2.16e-05	0.000249	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Methotrexate—hematologic cancer	2.16e-05	0.000248	CcSEcCtD
Acetylsalicylic acid—Dizziness—Alitretinoin—hematologic cancer	2.16e-05	0.000248	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Vincristine—hematologic cancer	2.15e-05	0.000247	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Methotrexate—hematologic cancer	2.15e-05	0.000247	CcSEcCtD
Acetylsalicylic acid—Sweating—Epirubicin—hematologic cancer	2.15e-05	0.000247	CcSEcCtD
Acetylsalicylic acid—Dizziness—Ifosfamide—hematologic cancer	2.13e-05	0.000245	CcSEcCtD
Acetylsalicylic acid—Pruritus—Gemcitabine—hematologic cancer	2.11e-05	0.000243	CcSEcCtD
Acetylsalicylic acid—Nausea—Thiotepa—hematologic cancer	2.11e-05	0.000242	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Etoposide—hematologic cancer	2.1e-05	0.000241	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Betamethasone—hematologic cancer	2.1e-05	0.000241	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Dexamethasone—hematologic cancer	2.1e-05	0.000241	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Irinotecan—hematologic cancer	2.09e-05	0.000241	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Mitoxantrone—hematologic cancer	2.09e-05	0.000241	CcSEcCtD
Acetylsalicylic acid—Vomiting—Carmustine—hematologic cancer	2.09e-05	0.000241	CcSEcCtD
Acetylsalicylic acid—Dizziness—Vincristine—hematologic cancer	2.08e-05	0.000239	CcSEcCtD
Acetylsalicylic acid—TP53—Danazol—Prednisone—hematologic cancer	2.08e-05	0.00997	CbGdCrCtD
Acetylsalicylic acid—Rash—Carmustine—hematologic cancer	2.08e-05	0.000239	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Carmustine—hematologic cancer	2.07e-05	0.000239	CcSEcCtD
Acetylsalicylic acid—Vomiting—Alitretinoin—hematologic cancer	2.07e-05	0.000239	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Doxorubicin—hematologic cancer	2.07e-05	0.000238	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Prednisolone—hematologic cancer	2.07e-05	0.000238	CcSEcCtD
Acetylsalicylic acid—Anaemia—Prednisone—hematologic cancer	2.07e-05	0.000238	CcSEcCtD
Acetylsalicylic acid—Shock—Dexamethasone—hematologic cancer	2.06e-05	0.000237	CcSEcCtD
Acetylsalicylic acid—Shock—Betamethasone—hematologic cancer	2.06e-05	0.000237	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Triamcinolone—hematologic cancer	2.06e-05	0.000237	CcSEcCtD
Acetylsalicylic acid—Rash—Alitretinoin—hematologic cancer	2.06e-05	0.000237	CcSEcCtD
Acetylsalicylic acid—Agitation—Prednisone—hematologic cancer	2.06e-05	0.000236	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Alitretinoin—hematologic cancer	2.06e-05	0.000236	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Dexamethasone—hematologic cancer	2.05e-05	0.000236	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Betamethasone—hematologic cancer	2.05e-05	0.000236	CcSEcCtD
Acetylsalicylic acid—Vomiting—Ifosfamide—hematologic cancer	2.05e-05	0.000236	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Cisplatin—hematologic cancer	2.05e-05	0.000236	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Dexamethasone—hematologic cancer	2.05e-05	0.000235	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Betamethasone—hematologic cancer	2.05e-05	0.000235	CcSEcCtD
Acetylsalicylic acid—Angioedema—Prednisone—hematologic cancer	2.04e-05	0.000235	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Gemcitabine—hematologic cancer	2.04e-05	0.000235	CcSEcCtD
Acetylsalicylic acid—Nausea—Thalidomide—hematologic cancer	2.04e-05	0.000234	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Triamcinolone—hematologic cancer	2.03e-05	0.000234	CcSEcCtD
Acetylsalicylic acid—Rash—Ifosfamide—hematologic cancer	2.03e-05	0.000234	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Ifosfamide—hematologic cancer	2.03e-05	0.000234	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Betamethasone—hematologic cancer	2.03e-05	0.000233	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Dexamethasone—hematologic cancer	2.03e-05	0.000233	CcSEcCtD
Acetylsalicylic acid—Dizziness—Irinotecan—hematologic cancer	2.02e-05	0.000233	CcSEcCtD
Acetylsalicylic acid—Urticaria—Etoposide—hematologic cancer	2.02e-05	0.000233	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Epirubicin—hematologic cancer	2.02e-05	0.000232	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisone—hematologic cancer	2.01e-05	0.000231	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Epirubicin—hematologic cancer	2.01e-05	0.000231	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisone—hematologic cancer	2.01e-05	0.000231	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Methotrexate—hematologic cancer	2e-05	0.00023	CcSEcCtD
Acetylsalicylic acid—Vomiting—Vincristine—hematologic cancer	2e-05	0.00023	CcSEcCtD
Acetylsalicylic acid—Urticaria—Prednisolone—hematologic cancer	2e-05	0.00023	CcSEcCtD
Acetylsalicylic acid—Sweating—Doxorubicin—hematologic cancer	1.99e-05	0.000228	CcSEcCtD
Acetylsalicylic acid—Rash—Vincristine—hematologic cancer	1.98e-05	0.000228	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Vincristine—hematologic cancer	1.98e-05	0.000228	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Prednisone—hematologic cancer	1.97e-05	0.000226	CcSEcCtD
Acetylsalicylic acid—Nausea—Carmustine—hematologic cancer	1.96e-05	0.000225	CcSEcCtD
Acetylsalicylic acid—Vomiting—Mitoxantrone—hematologic cancer	1.95e-05	0.000224	CcSEcCtD
Acetylsalicylic acid—Vomiting—Irinotecan—hematologic cancer	1.95e-05	0.000224	CcSEcCtD
Acetylsalicylic acid—Nausea—Alitretinoin—hematologic cancer	1.94e-05	0.000223	CcSEcCtD
Acetylsalicylic acid—Convulsion—Prednisone—hematologic cancer	1.94e-05	0.000223	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisone—hematologic cancer	1.93e-05	0.000222	CcSEcCtD
Acetylsalicylic acid—Rash—Mitoxantrone—hematologic cancer	1.93e-05	0.000222	CcSEcCtD
Acetylsalicylic acid—Rash—Irinotecan—hematologic cancer	1.93e-05	0.000222	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Irinotecan—hematologic cancer	1.93e-05	0.000222	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Mitoxantrone—hematologic cancer	1.93e-05	0.000222	CcSEcCtD
Acetylsalicylic acid—Nausea—Ifosfamide—hematologic cancer	1.92e-05	0.00022	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Prednisone—hematologic cancer	1.9e-05	0.000219	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Triamcinolone—hematologic cancer	1.9e-05	0.000219	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Cisplatin—hematologic cancer	1.9e-05	0.000219	CcSEcCtD
Acetylsalicylic acid—Vomiting—Gemcitabine—hematologic cancer	1.9e-05	0.000218	CcSEcCtD
Acetylsalicylic acid—Rash—Gemcitabine—hematologic cancer	1.88e-05	0.000216	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Gemcitabine—hematologic cancer	1.88e-05	0.000216	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Etoposide—hematologic cancer	1.88e-05	0.000216	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Epirubicin—hematologic cancer	1.87e-05	0.000216	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Doxorubicin—hematologic cancer	1.87e-05	0.000215	CcSEcCtD
Acetylsalicylic acid—Nausea—Vincristine—hematologic cancer	1.87e-05	0.000215	CcSEcCtD
Acetylsalicylic acid—Flushing—Epirubicin—hematologic cancer	1.86e-05	0.000215	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Doxorubicin—hematologic cancer	1.86e-05	0.000214	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Prednisolone—hematologic cancer	1.85e-05	0.000213	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Betamethasone—hematologic cancer	1.84e-05	0.000212	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Dexamethasone—hematologic cancer	1.84e-05	0.000212	CcSEcCtD
Acetylsalicylic acid—Urticaria—Triamcinolone—hematologic cancer	1.84e-05	0.000211	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Prednisone—hematologic cancer	1.83e-05	0.00021	CcSEcCtD
Acetylsalicylic acid—Nausea—Mitoxantrone—hematologic cancer	1.82e-05	0.000209	CcSEcCtD
Acetylsalicylic acid—Nausea—Irinotecan—hematologic cancer	1.82e-05	0.000209	CcSEcCtD
Acetylsalicylic acid—Pruritus—Etoposide—hematologic cancer	1.8e-05	0.000207	CcSEcCtD
Acetylsalicylic acid—Shock—Prednisone—hematologic cancer	1.8e-05	0.000207	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisone—hematologic cancer	1.78e-05	0.000205	CcSEcCtD
Acetylsalicylic acid—Nausea—Gemcitabine—hematologic cancer	1.77e-05	0.000204	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	1.77e-05	0.0085	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	1.77e-05	0.0085	CbGdCrCtD
Acetylsalicylic acid—Vomiting—Cisplatin—hematologic cancer	1.77e-05	0.000203	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Prednisone—hematologic cancer	1.76e-05	0.000203	CcSEcCtD
Acetylsalicylic acid—Rash—Cisplatin—hematologic cancer	1.75e-05	0.000202	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Cisplatin—hematologic cancer	1.75e-05	0.000201	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Etoposide—hematologic cancer	1.74e-05	0.0002	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Doxorubicin—hematologic cancer	1.73e-05	0.000199	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	1.73e-05	0.0083	CbGdCrCtD
Acetylsalicylic acid—Anaemia—Methotrexate—hematologic cancer	1.73e-05	0.000199	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Dexamethasone—hematologic cancer	1.73e-05	0.000199	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Betamethasone—hematologic cancer	1.73e-05	0.000199	CcSEcCtD
Acetylsalicylic acid—Flushing—Doxorubicin—hematologic cancer	1.73e-05	0.000199	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Triamcinolone—hematologic cancer	1.7e-05	0.000196	CcSEcCtD
Acetylsalicylic acid—Dizziness—Etoposide—hematologic cancer	1.68e-05	0.000194	CcSEcCtD
Acetylsalicylic acid—Vertigo—Methotrexate—hematologic cancer	1.68e-05	0.000193	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Methotrexate—hematologic cancer	1.67e-05	0.000192	CcSEcCtD
Acetylsalicylic acid—Urticaria—Betamethasone—hematologic cancer	1.67e-05	0.000192	CcSEcCtD
Acetylsalicylic acid—Urticaria—Dexamethasone—hematologic cancer	1.67e-05	0.000192	CcSEcCtD
Acetylsalicylic acid—Dizziness—Prednisolone—hematologic cancer	1.66e-05	0.000191	CcSEcCtD
Acetylsalicylic acid—Nausea—Cisplatin—hematologic cancer	1.65e-05	0.00019	CcSEcCtD
Acetylsalicylic acid—Pruritus—Triamcinolone—hematologic cancer	1.63e-05	0.000188	CcSEcCtD
Acetylsalicylic acid—Convulsion—Methotrexate—hematologic cancer	1.62e-05	0.000186	CcSEcCtD
Acetylsalicylic acid—Vomiting—Etoposide—hematologic cancer	1.62e-05	0.000186	CcSEcCtD
Acetylsalicylic acid—Anaemia—Epirubicin—hematologic cancer	1.62e-05	0.000186	CcSEcCtD
Acetylsalicylic acid—Agitation—Epirubicin—hematologic cancer	1.61e-05	0.000185	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Prednisone—hematologic cancer	1.61e-05	0.000185	CcSEcCtD
Acetylsalicylic acid—Rash—Etoposide—hematologic cancer	1.61e-05	0.000185	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Etoposide—hematologic cancer	1.6e-05	0.000185	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Methotrexate—hematologic cancer	1.59e-05	0.000183	CcSEcCtD
Acetylsalicylic acid—Chest pain—Methotrexate—hematologic cancer	1.59e-05	0.000183	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisolone—hematologic cancer	1.58e-05	0.000182	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisolone—hematologic cancer	1.58e-05	0.000182	CcSEcCtD
Acetylsalicylic acid—Vertigo—Epirubicin—hematologic cancer	1.57e-05	0.000181	CcSEcCtD
Acetylsalicylic acid—Syncope—Epirubicin—hematologic cancer	1.57e-05	0.00018	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Epirubicin—hematologic cancer	1.57e-05	0.00018	CcSEcCtD
Acetylsalicylic acid—Confusional state—Methotrexate—hematologic cancer	1.54e-05	0.000177	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Epirubicin—hematologic cancer	1.54e-05	0.000177	CcSEcCtD
Acetylsalicylic acid—Dizziness—Triamcinolone—hematologic cancer	1.53e-05	0.000176	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Methotrexate—hematologic cancer	1.53e-05	0.000175	CcSEcCtD
Acetylsalicylic acid—Convulsion—Epirubicin—hematologic cancer	1.52e-05	0.000174	CcSEcCtD
Acetylsalicylic acid—Nausea—Etoposide—hematologic cancer	1.51e-05	0.000174	CcSEcCtD
Acetylsalicylic acid—Hypertension—Epirubicin—hematologic cancer	1.51e-05	0.000174	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Prednisone—hematologic cancer	1.5e-05	0.000173	CcSEcCtD
Acetylsalicylic acid—Anaemia—Doxorubicin—hematologic cancer	1.5e-05	0.000172	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Methotrexate—hematologic cancer	1.49e-05	0.000172	CcSEcCtD
Acetylsalicylic acid—Nausea—Prednisolone—hematologic cancer	1.49e-05	0.000172	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Epirubicin—hematologic cancer	1.49e-05	0.000171	CcSEcCtD
Acetylsalicylic acid—Chest pain—Epirubicin—hematologic cancer	1.49e-05	0.000171	CcSEcCtD
Acetylsalicylic acid—Agitation—Doxorubicin—hematologic cancer	1.49e-05	0.000171	CcSEcCtD
Acetylsalicylic acid—Pruritus—Dexamethasone—hematologic cancer	1.48e-05	0.000171	CcSEcCtD
Acetylsalicylic acid—Pruritus—Betamethasone—hematologic cancer	1.48e-05	0.000171	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Methotrexate—hematologic cancer	1.47e-05	0.00017	CcSEcCtD
Acetylsalicylic acid—Vomiting—Triamcinolone—hematologic cancer	1.47e-05	0.000169	CcSEcCtD
Acetylsalicylic acid—Rash—Triamcinolone—hematologic cancer	1.46e-05	0.000168	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Triamcinolone—hematologic cancer	1.46e-05	0.000167	CcSEcCtD
Acetylsalicylic acid—Vertigo—Doxorubicin—hematologic cancer	1.45e-05	0.000167	CcSEcCtD
Acetylsalicylic acid—Syncope—Doxorubicin—hematologic cancer	1.45e-05	0.000167	CcSEcCtD
Acetylsalicylic acid—Urticaria—Prednisone—hematologic cancer	1.45e-05	0.000167	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Doxorubicin—hematologic cancer	1.45e-05	0.000167	CcSEcCtD
Acetylsalicylic acid—Confusional state—Epirubicin—hematologic cancer	1.44e-05	0.000166	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Betamethasone—hematologic cancer	1.43e-05	0.000165	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Dexamethasone—hematologic cancer	1.43e-05	0.000165	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Epirubicin—hematologic cancer	1.43e-05	0.000164	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Doxorubicin—hematologic cancer	1.42e-05	0.000164	CcSEcCtD
Acetylsalicylic acid—Shock—Epirubicin—hematologic cancer	1.4e-05	0.000162	CcSEcCtD
Acetylsalicylic acid—Convulsion—Doxorubicin—hematologic cancer	1.4e-05	0.000161	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Epirubicin—hematologic cancer	1.4e-05	0.000161	CcSEcCtD
Acetylsalicylic acid—Hypertension—Doxorubicin—hematologic cancer	1.4e-05	0.000161	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Epirubicin—hematologic cancer	1.39e-05	0.00016	CcSEcCtD
Acetylsalicylic acid—Dizziness—Dexamethasone—hematologic cancer	1.39e-05	0.000159	CcSEcCtD
Acetylsalicylic acid—Dizziness—Betamethasone—hematologic cancer	1.39e-05	0.000159	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Epirubicin—hematologic cancer	1.38e-05	0.000159	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Doxorubicin—hematologic cancer	1.38e-05	0.000159	CcSEcCtD
Acetylsalicylic acid—Chest pain—Doxorubicin—hematologic cancer	1.38e-05	0.000159	CcSEcCtD
Acetylsalicylic acid—Nausea—Triamcinolone—hematologic cancer	1.37e-05	0.000158	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Methotrexate—hematologic cancer	1.36e-05	0.000156	CcSEcCtD
Acetylsalicylic acid—Somnolence—Methotrexate—hematologic cancer	1.36e-05	0.000156	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Prednisone—hematologic cancer	1.34e-05	0.000155	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Methotrexate—hematologic cancer	1.34e-05	0.000154	CcSEcCtD
Acetylsalicylic acid—Vomiting—Dexamethasone—hematologic cancer	1.33e-05	0.000153	CcSEcCtD
Acetylsalicylic acid—Vomiting—Betamethasone—hematologic cancer	1.33e-05	0.000153	CcSEcCtD
Acetylsalicylic acid—Confusional state—Doxorubicin—hematologic cancer	1.33e-05	0.000153	CcSEcCtD
Acetylsalicylic acid—Rash—Betamethasone—hematologic cancer	1.32e-05	0.000152	CcSEcCtD
Acetylsalicylic acid—Rash—Dexamethasone—hematologic cancer	1.32e-05	0.000152	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Doxorubicin—hematologic cancer	1.32e-05	0.000152	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Dexamethasone—hematologic cancer	1.32e-05	0.000152	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Betamethasone—hematologic cancer	1.32e-05	0.000152	CcSEcCtD
Acetylsalicylic acid—Shock—Doxorubicin—hematologic cancer	1.3e-05	0.00015	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Doxorubicin—hematologic cancer	1.29e-05	0.000149	CcSEcCtD
Acetylsalicylic acid—Pruritus—Prednisone—hematologic cancer	1.29e-05	0.000149	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Doxorubicin—hematologic cancer	1.29e-05	0.000148	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Doxorubicin—hematologic cancer	1.28e-05	0.000147	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Epirubicin—hematologic cancer	1.27e-05	0.000146	CcSEcCtD
Acetylsalicylic acid—Somnolence—Epirubicin—hematologic cancer	1.27e-05	0.000146	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Methotrexate—hematologic cancer	1.26e-05	0.000145	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Epirubicin—hematologic cancer	1.26e-05	0.000145	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Prednisone—hematologic cancer	1.25e-05	0.000144	CcSEcCtD
Acetylsalicylic acid—Nausea—Betamethasone—hematologic cancer	1.24e-05	0.000143	CcSEcCtD
Acetylsalicylic acid—Nausea—Dexamethasone—hematologic cancer	1.24e-05	0.000143	CcSEcCtD
Acetylsalicylic acid—Urticaria—Methotrexate—hematologic cancer	1.21e-05	0.000139	CcSEcCtD
Acetylsalicylic acid—Dizziness—Prednisone—hematologic cancer	1.21e-05	0.000139	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Doxorubicin—hematologic cancer	1.18e-05	0.000135	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Epirubicin—hematologic cancer	1.18e-05	0.000135	CcSEcCtD
Acetylsalicylic acid—Somnolence—Doxorubicin—hematologic cancer	1.17e-05	0.000135	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Doxorubicin—hematologic cancer	1.16e-05	0.000134	CcSEcCtD
Acetylsalicylic acid—Vomiting—Prednisone—hematologic cancer	1.16e-05	0.000134	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisone—hematologic cancer	1.15e-05	0.000132	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisone—hematologic cancer	1.15e-05	0.000132	CcSEcCtD
Acetylsalicylic acid—Urticaria—Epirubicin—hematologic cancer	1.13e-05	0.00013	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Methotrexate—hematologic cancer	1.12e-05	0.000129	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Doxorubicin—hematologic cancer	1.09e-05	0.000125	CcSEcCtD
Acetylsalicylic acid—Nausea—Prednisone—hematologic cancer	1.08e-05	0.000125	CcSEcCtD
Acetylsalicylic acid—Pruritus—Methotrexate—hematologic cancer	1.08e-05	0.000124	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	1.07e-05	0.00513	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	1.07e-05	0.00513	CbGdCrCtD
Acetylsalicylic acid—Hypersensitivity—Epirubicin—hematologic cancer	1.05e-05	0.000121	CcSEcCtD
Acetylsalicylic acid—Urticaria—Doxorubicin—hematologic cancer	1.05e-05	0.000121	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	1.04e-05	0.00501	CbGdCrCtD
Acetylsalicylic acid—Diarrhoea—Methotrexate—hematologic cancer	1.04e-05	0.00012	CcSEcCtD
Acetylsalicylic acid—Pruritus—Epirubicin—hematologic cancer	1.01e-05	0.000116	CcSEcCtD
Acetylsalicylic acid—Dizziness—Methotrexate—hematologic cancer	1.01e-05	0.000116	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Epirubicin—hematologic cancer	9.77e-06	0.000112	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Doxorubicin—hematologic cancer	9.73e-06	0.000112	CcSEcCtD
Acetylsalicylic acid—Vomiting—Methotrexate—hematologic cancer	9.7e-06	0.000112	CcSEcCtD
Acetylsalicylic acid—Rash—Methotrexate—hematologic cancer	9.62e-06	0.000111	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methotrexate—hematologic cancer	9.61e-06	0.000111	CcSEcCtD
Acetylsalicylic acid—Dizziness—Epirubicin—hematologic cancer	9.44e-06	0.000109	CcSEcCtD
Acetylsalicylic acid—Pruritus—Doxorubicin—hematologic cancer	9.35e-06	0.000108	CcSEcCtD
Acetylsalicylic acid—Vomiting—Epirubicin—hematologic cancer	9.08e-06	0.000104	CcSEcCtD
Acetylsalicylic acid—Nausea—Methotrexate—hematologic cancer	9.06e-06	0.000104	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Doxorubicin—hematologic cancer	9.04e-06	0.000104	CcSEcCtD
Acetylsalicylic acid—Rash—Epirubicin—hematologic cancer	9e-06	0.000104	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Epirubicin—hematologic cancer	8.99e-06	0.000103	CcSEcCtD
Acetylsalicylic acid—Dizziness—Doxorubicin—hematologic cancer	8.73e-06	0.0001	CcSEcCtD
Acetylsalicylic acid—Nausea—Epirubicin—hematologic cancer	8.48e-06	9.76e-05	CcSEcCtD
Acetylsalicylic acid—Vomiting—Doxorubicin—hematologic cancer	8.4e-06	9.66e-05	CcSEcCtD
Acetylsalicylic acid—Rash—Doxorubicin—hematologic cancer	8.33e-06	9.58e-05	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Doxorubicin—hematologic cancer	8.32e-06	9.57e-05	CcSEcCtD
Acetylsalicylic acid—Nausea—Doxorubicin—hematologic cancer	7.85e-06	9.03e-05	CcSEcCtD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FN1—hematologic cancer	6.03e-07	5.99e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HSP90AA1—hematologic cancer	6.03e-07	5.98e-06	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PIK3CA—hematologic cancer	5.99e-07	5.95e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NFKBIA—hematologic cancer	5.96e-07	5.92e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—BAD—hematologic cancer	5.96e-07	5.92e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.96e-07	5.92e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CDKN1A—hematologic cancer	5.92e-07	5.88e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.92e-07	5.88e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PTEN—hematologic cancer	5.91e-07	5.87e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NOTCH1—hematologic cancer	5.9e-07	5.86e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KRAS—hematologic cancer	5.9e-07	5.86e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KRAS—hematologic cancer	5.9e-07	5.86e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.89e-07	5.85e-06	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—hematologic cancer	5.87e-07	5.83e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FGFR3—hematologic cancer	5.86e-07	5.82e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—AKT1—hematologic cancer	5.85e-07	5.81e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.82e-07	5.78e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MAPK8—hematologic cancer	5.78e-07	5.74e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CD80—hematologic cancer	5.78e-07	5.74e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CG—hematologic cancer	5.77e-07	5.73e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KIT—hematologic cancer	5.77e-07	5.73e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NQO1—hematologic cancer	5.75e-07	5.71e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CD44—hematologic cancer	5.75e-07	5.71e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—EP300—hematologic cancer	5.68e-07	5.64e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CG—hematologic cancer	5.68e-07	5.64e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTPN11—hematologic cancer	5.67e-07	5.63e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EP300—hematologic cancer	5.64e-07	5.6e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.63e-07	5.6e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CD44—hematologic cancer	5.62e-07	5.58e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NQO1—hematologic cancer	5.62e-07	5.58e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—AKT1—hematologic cancer	5.61e-07	5.58e-06	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HRAS—hematologic cancer	5.61e-07	5.57e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.56e-07	5.53e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—BAD—hematologic cancer	5.56e-07	5.52e-06	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HRAS—hematologic cancer	5.54e-07	5.51e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—SRC—hematologic cancer	5.52e-07	5.49e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOTCH1—hematologic cancer	5.5e-07	5.47e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CREB1—hematologic cancer	5.49e-07	5.46e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—SRC—hematologic cancer	5.48e-07	5.44e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.45e-07	5.42e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYCS—hematologic cancer	5.44e-07	5.41e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—BRAF—hematologic cancer	5.42e-07	5.39e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.42e-07	5.39e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PIK3CA—hematologic cancer	5.42e-07	5.38e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PIK3CA—hematologic cancer	5.42e-07	5.38e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	5.41e-07	5.37e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD80—hematologic cancer	5.39e-07	5.36e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KIT—hematologic cancer	5.38e-07	5.35e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—hematologic cancer	5.38e-07	5.34e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTP1—hematologic cancer	5.38e-07	5.34e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCL2—hematologic cancer	5.37e-07	5.34e-06	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—hematologic cancer	5.37e-07	5.33e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MTHFR—hematologic cancer	5.37e-07	5.33e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6R—hematologic cancer	5.36e-07	5.32e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CREBBP—hematologic cancer	5.35e-07	5.31e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTP1—hematologic cancer	5.35e-07	5.31e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NRAS—hematologic cancer	5.31e-07	5.28e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYCS—hematologic cancer	5.31e-07	5.28e-06	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—hematologic cancer	5.31e-07	5.27e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PTPN11—hematologic cancer	5.29e-07	5.25e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—STAT3—hematologic cancer	5.29e-07	5.25e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HSP90AA1—hematologic cancer	5.28e-07	5.24e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NRAS—hematologic cancer	5.27e-07	5.24e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CREBBP—hematologic cancer	5.27e-07	5.23e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NQO1—hematologic cancer	5.25e-07	5.21e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CD44—hematologic cancer	5.25e-07	5.21e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—hematologic cancer	5.24e-07	5.21e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—hematologic cancer	5.24e-07	5.21e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.2e-07	5.17e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.17e-07	5.14e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.14e-07	5.1e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CREB1—hematologic cancer	5.12e-07	5.09e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAP2K1—hematologic cancer	5.11e-07	5.07e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—MAPK3—hematologic cancer	5.09e-07	5.05e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ABCB1—hematologic cancer	5.09e-07	5.05e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CD—hematologic cancer	5.07e-07	5.04e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—BRAF—hematologic cancer	5.06e-07	5.03e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ABCB1—hematologic cancer	5.06e-07	5.03e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MAPK3—hematologic cancer	5.05e-07	5.02e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HRAS—hematologic cancer	5.01e-07	4.98e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HRAS—hematologic cancer	5.01e-07	4.98e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6R—hematologic cancer	5e-07	4.96e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CD—hematologic cancer	4.99e-07	4.96e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CREBBP—hematologic cancer	4.99e-07	4.96e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYCS—hematologic cancer	4.96e-07	4.93e-06	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—AKT1—hematologic cancer	4.95e-07	4.92e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTM1—hematologic cancer	4.94e-07	4.91e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NCOR1—hematologic cancer	4.94e-07	4.91e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TGFB1—hematologic cancer	4.94e-07	4.9e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.93e-07	4.9e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ALB—hematologic cancer	4.93e-07	4.89e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NCOR1—hematologic cancer	4.91e-07	4.88e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTM1—hematologic cancer	4.91e-07	4.88e-06	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKT1—hematologic cancer	4.9e-07	4.86e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.87e-07	4.84e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FGF2—hematologic cancer	4.86e-07	4.82e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—hematologic cancer	4.8e-07	4.77e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—hematologic cancer	4.8e-07	4.77e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTP1—hematologic cancer	4.8e-07	4.77e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3R1—hematologic cancer	4.79e-07	4.76e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MAP2K1—hematologic cancer	4.76e-07	4.73e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CD—hematologic cancer	4.73e-07	4.7e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.73e-07	4.7e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3R1—hematologic cancer	4.71e-07	4.68e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTP1—hematologic cancer	4.68e-07	4.65e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—JAK2—hematologic cancer	4.66e-07	4.62e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.64e-07	4.61e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—KRAS—hematologic cancer	4.57e-07	4.54e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MDM2—hematologic cancer	4.54e-07	4.51e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ABCB1—hematologic cancer	4.54e-07	4.51e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KRAS—hematologic cancer	4.54e-07	4.51e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FGF2—hematologic cancer	4.53e-07	4.5e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CG—hematologic cancer	4.51e-07	4.48e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3R1—hematologic cancer	4.47e-07	4.44e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.44e-07	4.41e-06	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKT1—hematologic cancer	4.43e-07	4.4e-06	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKT1—hematologic cancer	4.43e-07	4.4e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MTOR—hematologic cancer	4.42e-07	4.39e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CB—hematologic cancer	4.42e-07	4.39e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTM1—hematologic cancer	4.41e-07	4.38e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NCOR1—hematologic cancer	4.41e-07	4.38e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.38e-07	4.35e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MTHFR—hematologic cancer	4.37e-07	4.34e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CB—hematologic cancer	4.35e-07	4.32e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—JAK2—hematologic cancer	4.34e-07	4.31e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MTHFR—hematologic cancer	4.34e-07	4.31e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NCOR1—hematologic cancer	4.3e-07	4.27e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTM1—hematologic cancer	4.3e-07	4.27e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MDM2—hematologic cancer	4.24e-07	4.21e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.23e-07	4.2e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PIK3CA—hematologic cancer	4.2e-07	4.17e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CREBBP—hematologic cancer	4.18e-07	4.15e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PIK3CA—hematologic cancer	4.17e-07	4.14e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN1B—hematologic cancer	4.15e-07	4.12e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.14e-07	4.11e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MTOR—hematologic cancer	4.12e-07	4.1e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CB—hematologic cancer	4.12e-07	4.1e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD4—hematologic cancer	4.12e-07	4.09e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CASP3—hematologic cancer	4.07e-07	4.04e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—hematologic cancer	4.07e-07	4.04e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2—hematologic cancer	4.06e-07	4.03e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NCOR1—hematologic cancer	4.02e-07	3.99e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTM1—hematologic cancer	4.02e-07	3.99e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CD—hematologic cancer	3.96e-07	3.94e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCND1—hematologic cancer	3.96e-07	3.93e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—JUN—hematologic cancer	3.95e-07	3.92e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ALB—hematologic cancer	3.91e-07	3.89e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.9e-07	3.87e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HRAS—hematologic cancer	3.89e-07	3.86e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN1B—hematologic cancer	3.87e-07	3.84e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HRAS—hematologic cancer	3.86e-07	3.83e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.85e-07	3.82e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN1A—hematologic cancer	3.83e-07	3.8e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.83e-07	3.8e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTEN—hematologic cancer	3.82e-07	3.79e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MTHFR—hematologic cancer	3.8e-07	3.78e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTEN—hematologic cancer	3.76e-07	3.73e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3R1—hematologic cancer	3.74e-07	3.72e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAPK8—hematologic cancer	3.74e-07	3.71e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—hematologic cancer	3.69e-07	3.67e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.67e-07	3.64e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CG—hematologic cancer	3.65e-07	3.62e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EP300—hematologic cancer	3.64e-07	3.62e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—EP300—hematologic cancer	3.59e-07	3.56e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN1A—hematologic cancer	3.57e-07	3.55e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PTEN—hematologic cancer	3.56e-07	3.54e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.55e-07	3.53e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SRC—hematologic cancer	3.54e-07	3.52e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CB—hematologic cancer	3.45e-07	3.43e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—hematologic cancer	3.45e-07	3.43e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.43e-07	3.41e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—AKT1—hematologic cancer	3.43e-07	3.41e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—STAT3—hematologic cancer	3.42e-07	3.39e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NRAS—hematologic cancer	3.41e-07	3.39e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AKT1—hematologic cancer	3.41e-07	3.38e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CREBBP—hematologic cancer	3.4e-07	3.38e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EP300—hematologic cancer	3.4e-07	3.38e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CREBBP—hematologic cancer	3.38e-07	3.36e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SRC—hematologic cancer	3.31e-07	3.28e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.27e-07	3.25e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAPK3—hematologic cancer	3.26e-07	3.24e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CD—hematologic cancer	3.22e-07	3.2e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CD—hematologic cancer	3.21e-07	3.18e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.2e-07	3.17e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—STAT3—hematologic cancer	3.19e-07	3.17e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ALB—hematologic cancer	3.18e-07	3.16e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NRAS—hematologic cancer	3.18e-07	3.16e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MYC—hematologic cancer	3.18e-07	3.15e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TGFB1—hematologic cancer	3.17e-07	3.15e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.13e-07	3.11e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MAPK3—hematologic cancer	3.05e-07	3.02e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3R1—hematologic cancer	3.04e-07	3.02e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CREBBP—hematologic cancer	3.04e-07	3.02e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3R1—hematologic cancer	3.03e-07	3.01e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.99e-07	2.97e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PTEN—hematologic cancer	2.98e-07	2.96e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CREBBP—hematologic cancer	2.96e-07	2.94e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MYC—hematologic cancer	2.96e-07	2.94e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TGFB1—hematologic cancer	2.95e-07	2.93e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KRAS—hematologic cancer	2.93e-07	2.91e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.88e-07	2.86e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—EP300—hematologic cancer	2.85e-07	2.83e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ALB—hematologic cancer	2.84e-07	2.82e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.81e-07	2.79e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.81e-07	2.79e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CB—hematologic cancer	2.79e-07	2.78e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ALB—hematologic cancer	2.77e-07	2.75e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.77e-07	2.75e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KRAS—hematologic cancer	2.74e-07	2.72e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.72e-07	2.7e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CA—hematologic cancer	2.7e-07	2.68e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.65e-07	2.63e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CA—hematologic cancer	2.65e-07	2.63e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.62e-07	2.61e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—hematologic cancer	2.61e-07	2.59e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ALB—hematologic cancer	2.59e-07	2.57e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PIK3CA—hematologic cancer	2.51e-07	2.5e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.51e-07	2.49e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HRAS—hematologic cancer	2.49e-07	2.48e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.48e-07	2.46e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.45e-07	2.43e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTEN—hematologic cancer	2.43e-07	2.41e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTEN—hematologic cancer	2.41e-07	2.4e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—hematologic cancer	2.39e-07	2.37e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HRAS—hematologic cancer	2.33e-07	2.31e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—EP300—hematologic cancer	2.32e-07	2.3e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—EP300—hematologic cancer	2.3e-07	2.29e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.29e-07	2.27e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—hematologic cancer	2.23e-07	2.21e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT1—hematologic cancer	2.2e-07	2.19e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTEN—hematologic cancer	2.17e-07	2.15e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AKT1—hematologic cancer	2.17e-07	2.15e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTEN—hematologic cancer	2.12e-07	2.1e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CA—hematologic cancer	2.11e-07	2.09e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—EP300—hematologic cancer	2.07e-07	2.05e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT1—hematologic cancer	2.05e-07	2.04e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—EP300—hematologic cancer	2.02e-07	2e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTEN—hematologic cancer	1.98e-07	1.96e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—EP300—hematologic cancer	1.89e-07	1.87e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKT1—hematologic cancer	1.72e-07	1.71e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.71e-07	1.7e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CA—hematologic cancer	1.7e-07	1.69e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.53e-07	1.52e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.49e-07	1.48e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKT1—hematologic cancer	1.4e-07	1.39e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.39e-07	1.39e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKT1—hematologic cancer	1.39e-07	1.38e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKT1—hematologic cancer	1.25e-07	1.24e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKT1—hematologic cancer	1.22e-07	1.21e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKT1—hematologic cancer	1.14e-07	1.13e-06	CbGpPWpGaD
